Nanoparticulate Impurities Isolated from Pharmaceutical-Grade Sucrose Are a Potential Threat to Protein Stability.

about

Nanoparticulate Impurities Isolated from Pharmaceutical-Grade Sucrose Are a Potential Threat to Protein Stability.

Item

http://www.wikidata.org/entity/Q46275499

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Nanoparticulate Impurities Iso ...... l Threat to Protein Stability.

@en

Nanoparticulate Impurities Iso ...... l Threat to Protein Stability.

@nl

type

Item

label

Nanoparticulate Impurities Iso ...... l Threat to Protein Stability.

@en

Nanoparticulate Impurities Iso ...... l Threat to Protein Stability.

@nl

prefLabel

Nanoparticulate Impurities Iso ...... l Threat to Protein Stability.

@en

Nanoparticulate Impurities Iso ...... l Threat to Protein Stability.

@nl

P1476

Nanoparticulate Impurities Iso ...... al Threat to Protein Stability

@en

P2093

Andrea Hawe

http://www.w3.org/2001/XMLSchema#string

Daniel Weinbuch

http://www.w3.org/2001/XMLSchema#string

Wim Jiskoot

http://www.w3.org/2001/XMLSchema#string

P2860

Protein aggregation and its impact on product quality

Stabilization of protein structure by sugars.

Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data.

Chemical modifications in aggregates of recombinant human insulin induced by metal-catalyzed oxidation: covalent cross-linking via michael addition to tyrosine oxidation products.

Practical formulation and process development of freeze-dried products.

Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice.

Effects of protein aggregates: an immunologic perspective

Identification of oxidation sites and covalent cross-links in metal catalyzed oxidized interferon Beta-1a: potential implications for protein aggregation and immunogenicity

An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics.

Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development.

P304

2910-2921

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-017-2274-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mitchel J R Ruigrok

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29067591

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle